Publications by authors named "Patrick M McCarthy"

Objective: Limited data are available on treatment of atrial fibrillation during ascending aortic aneurysm and aortic valve surgery. Ablation at the time of isolated aortic valve surgery has a Society of Thoracic Surgeons Class I indication. We sought to determine early and late outcomes of concomitant atrial fibrillation surgery at the time of ascending aortic aneurysm + aortic valve surgery.

View Article and Find Full Text PDF

Objectives: Visual estimation of coronary artery stenosis on angiography is subject to human error. While machine learning may facilitate more accurate interpretation, clinical utility has been limited by lack of human interpretable models. We developed an automated computer vision model to identify candidates for coronary artery bypass (CABG) from coronary angiograms.

View Article and Find Full Text PDF

Real time 2D phase contrast (RTPC) MRI is useful for flow quantification in atrial fibrillation (AF) patients, but data analysis requires time-consuming anatomical contouring for many cardiac time frames. Our goal was to develop a convolutional neural network (CNN) for fully automated left atrial (LA) flow quantification. Forty-four AF patients underwent cardiac MRI including LA RTPC, collecting a median of 358 timeframes per scan.

View Article and Find Full Text PDF

Background: Aortic root enlargement (ARE) during aortic valve replacement (AVR) mitigates prosthesis-patient mismatch, but its use has been low. Transcatheter aortic valve-in-valve (VIV) as a treatment for failing bioprosthetic valves is limited by small surgical valves, renewing interest in ARE during the index AVR. This study demonstrates trends and outcomes of ARE after commercial approval of VIV in 2015.

View Article and Find Full Text PDF
Article Synopsis
  • Untreated severe tricuspid regurgitation (TR) is linked to poor health outcomes, making effective treatment essential.
  • The study evaluated the 1-year results of transcatheter edge-to-edge repair (TEER) using the TriClip system in patients with complex tricuspid valve issues, finding significant improvements in patient survival and quality of life.
  • Results showed that 81% of patients experienced a reduction in TR to moderate or less after one year, with no major adverse effects noted in the first 30 days post-procedure.
View Article and Find Full Text PDF
Article Synopsis
  • - The TRILUMINATE Pivotal trial assessed the effects of tricuspid transcatheter edge-to-edge repair (T-TEER) on reducing tricuspid regurgitation (TR), a significant heart condition linked to increased health risks.
  • - Involving 572 patients, mostly elderly women with prior heart conditions, the trial found that T-TEER effectively improved quality of life, with nearly half of those treated experiencing significant improvements in heart health assessments.
  • - Results showed that while the treatment and control groups had similar rates of survival and heart-related surgeries, those who underwent T-TEER had notably better outcomes in TR severity and overall quality of life.
View Article and Find Full Text PDF
Article Synopsis
  • * The LeAAPS trial is a large, international study involving 6,500 patients to evaluate the effectiveness of LAAE for preventing strokes during cardiac surgery, with strict inclusion criteria and randomization methods.
  • * The trial will assess various outcomes including stroke incidents and safety events over a five-year follow-up to establish how effective and safe LAAE is in this patient population.
View Article and Find Full Text PDF

Background: The autologous tumor lysate, particle-loaded, dendritic cell (TLPLDC) vaccine is produced from dendritic cells (DC) loaded ex vivo with autologous tumor lysate (TL). TLPLDC has been shown to decrease recurrence in resected Stage III/IV melanoma patients in a Phase IIb trial. The TL particle only (TLPO) vaccine is produced by loading of yeast cell wall particles with autologous TL and direct injection allowing for in vivo DC loading.

View Article and Find Full Text PDF
Article Synopsis
  • A meta-analysis evaluated the impact of left atrial appendage occlusion (LAAO) on cerebrovascular accidents (CVAs) in patients without prior atrial fibrillation (AF) undergoing cardiac surgery.
  • Out of 4130 patients studied, those with LAAO had lower 5-year CVA rates (4.3%) compared to those without (6.8%), indicating a decreased risk associated with LAAO.
  • The analysis also suggested no difference in postoperative AF rates between groups, but a significant survival benefit for patients with LAAO after 4 years, emphasizing the need for further trials to confirm these findings.
View Article and Find Full Text PDF
Article Synopsis
  • The TRILUMINATE Pivotal trial investigated the impact of tricuspid regurgitation (TR) on end-organ function and the effectiveness of transcatheter edge-to-edge repair (TEER) compared to medical therapy alone in patients with severe TR.
  • The study included 572 patients who were split into TEER and control groups, examining how changes in end-organ function correlate with hospitalizations for heart failure (HF) and mortality over 12 months.
  • Results showed that while TEER did not significantly differ from medical therapy alone in overall end-organ function improvements, successful TEER did lead to enhanced function in specific patient subgroups, indicating potential benefits in targeted treatment.
View Article and Find Full Text PDF

Artificial Intelligence (AI) has greatly affected our everyday lives and holds great promise to change the landscape of medicine. AI is particularly positioned to improve care for the increasingly complex patients undergoing cardiac surgery using the immense amount of data generated in the course of their care. When deployed, AI can be used to analyze this information at the patient's bedside more expediently and accurately, all while providing new insights.

View Article and Find Full Text PDF
Article Synopsis
  • This study explored the feasibility of performing valve-in-valve transcatheter aortic valve implantation following aortic root replacement in 74 patients, using retrospective data collected from 2019 to 2021.
  • Results showed significant differences in the modeled versus manually measured distances between valves and coronary arteries, indicating most patients had low risk for coronary obstruction.
  • The research concluded that all patients were suitable candidates for the valve-in-valve procedure, although self-expanding valves had a higher risk of deformation while balloon-expandable valves posed a greater risk of coronary obstruction.
View Article and Find Full Text PDF
Article Synopsis
  • Patients increasingly prefer bioprosthetic valves for aortic valve replacement (AVR) to avoid anticoagulation, but the impact of patient-prosthesis mismatch (PPM) on valve durability remains under-studied.
  • A study evaluated 2,100 patients who underwent surgical AVR with the Magna bioprosthesis, revealing that smaller valve sizes correlated with poorer survival but not higher rates of reintervention.
  • Overall, reintervention rates after 15 years were low, but higher initial mean gradients at implant were linked to increased late reinterventions.
View Article and Find Full Text PDF

Background: The benefit of adjuvant therapy (AT) remains unclear in pancreatic ductal adenocarcinoma (PDAC) after neoadjuvant therapy (NAT) and surgical resection.

Methods: The 2019 National Cancer Database was queried for patients with non-metastatic PDAC who received NAT followed by pancreaticoduodenectomy. Only patients with data regarding receipt of AT were included.

View Article and Find Full Text PDF

Background: Transcatheter mitral valve-in-valve (MViV) replacement has emerged as an alternative to redo mitral valve (MV) surgery for the management of failed bioprosthetic MVs. The degree of cardiac remodeling assessed by echocardiography has been shown to have prognostic implications in degenerative mitral regurgitation patients undergoing MV surgery. The impact of transcatheter MViV in patients with degenerative bioprosthetic MV failure on cardiac remodeling and its associated prognosis remains undescribed.

View Article and Find Full Text PDF

Background: The management of aortic stenosis has evolved to stratification by age as reflected in recent societal guidelines. We evaluated age-stratified surgical aortic valve replacement (SAVR) trends and outcomes in patients with bicuspid aortic valve (BAV) or tricuspid aortic valve (TAV) from The Society of Thoracic Surgeons Adult Cardiac Surgery Database.

Methods: This cohort included adults (≥18 years) undergoing SAVR for severe aortic stenosis between July 2011 and December 2022.

View Article and Find Full Text PDF

Objective: Acupuncture is an effective treatment for arrythmias and postoperative symptoms but has not been investigated after cardiac surgery. Acupuncture After Heart Surgery is a prospective, randomized, controlled pilot trial of daily inpatient acupuncture or standard care after valve surgery with the primary end point being feasibility and secondary end points being reduction in postoperative atrial fibrillation incidence and postoperative symptoms.

Methods: A total of 100 patients without a history of atrial fibrillation underwent primary valve surgery via sternotomy and randomized 1:1 to acupuncture (51) or standard care (49).

View Article and Find Full Text PDF
Article Synopsis
  • The "2023 ACC/AHA/ACCP/HRS Guideline for the Diagnosis and Management of Patients With Atrial Fibrillation" aims to provide updated recommendations for clinicians treating atrial fibrillation patients.
  • A thorough literature review was conducted to gather evidence from various medical databases, including studies and reviews published on human subjects from May to November 2022.
  • The guideline updates previous recommendations, introducing new strategies for thromboembolic risk assessment, anticoagulation, and methods for prevention and management of atrial fibrillation.
View Article and Find Full Text PDF
Article Synopsis
  • The 2023 guideline aims to provide healthcare professionals with updated recommendations for diagnosing and managing patients with atrial fibrillation.
  • A thorough literature review was conducted to gather relevant studies and evidence from multiple databases, ensuring the guideline reflects current knowledge and practices.
  • The guidelines build upon earlier recommendations, introducing new insights on thromboembolic risk, anticoagulation, surgical options, and preventive measures related to atrial fibrillation.
View Article and Find Full Text PDF

Objective: New permanent pacemaker (PPM) implantation after concomitant atrial fibrillation (AF) ablation has been associated with surgical ablation (SA). We sought to determine factors for PPM use as well as early rhythm recovery.

Methods: From 2004 through 2019, 6135 patients underwent valve surgery and were grouped: No AF (n = 4584), AF no SA (n = 346), and AF with SA (n = 1205) to evaluate predischarge PPM and 3-month rhythm recovery (intrinsic heart rate >40 beats per minute).

View Article and Find Full Text PDF

Objective: Guideline recommendations for mechanical or bioprosthetic valve for mitral valve replacement by age remains controversial. We sought to determine bovine pericardial valve durability by age and risk of reintervention.

Methods: This retrospective study between 2 large university-based cardiac surgery programs examined patients who underwent bioprosthetic mitral valve replacement from 2004 to 2020.

View Article and Find Full Text PDF